Increasing the therapeutic ratio of pelvic radiotherapy for rectal cancer by blocking calcium/calmodulin-dependent protein kinase kinase 2

Awarded By

  • Duke Cancer Institute

Contributors

Start/End

  • July 2019 - June 2020